Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Franzone

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
American Heart Journal|June 5, 2024
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after transcatheter aortic valve replacement: Insights from the Recovery-TAVR registryFrancesco Bruno, Joao Matteo Rampone, Fabian Islas, et al.
JACC. Cardiovascular Interventions|February 19, 2021
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-AnalysisMarco Valgimigli, Roxana Mehran, Anna Franzone, et al.
JACC. Cardiovascular Interventions|November 26, 2025
Clinical Impact of In-Hospital Hemoglobin Decline Without Overt Bleeding After Transcatheter Aortic Valve ReplacementMarisa Avvedimento, Pedro Cepas-Guillén, Jorge Nuche, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trialRaffaele Piccolo, Paolo Calabrò, Greta Carrara, et al.
Revista Espanola De Cardiologia (English Ed.)|December 26, 2024
Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impactAriana Gonzálvez-García, Pedro Cepas-Guillén, Julien Ternacle, et al.
Journal of Clinical Medicine|June 27, 2024
Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve ImplantationSofia Sammartino, Giulia Laterra, Thomas Pilgrim, et al.
Circulation. Cardiovascular Interventions|October 30, 2024
Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVRMarisa Avvedimento, Pedro Cepas-Guillén, Julien Ternacle, et al.
Circulation. Cardiovascular Interventions|December 20, 2022
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve ImplantationGiuliano Costa, Thomas Pilgrim, Ignacio J Amat Santos, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 12, 2023
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantationTobias Rheude, Giuliano Costa, Flavio Luciano Ribichini, et al.
Circulation. Cardiovascular Interventions|May 20, 2026
Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve ImplantationCristina Aurigemma, Giuliano Costa, Giulia Laterra, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
American Heart Journal|June 5, 2024
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after transcatheter aortic valve replacement: Insights from the Recovery-TAVR registryFrancesco Bruno, Joao Matteo Rampone, Fabian Islas, et al.
JACC. Cardiovascular Interventions|February 19, 2021
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-AnalysisMarco Valgimigli, Roxana Mehran, Anna Franzone, et al.
JACC. Cardiovascular Interventions|November 26, 2025
Clinical Impact of In-Hospital Hemoglobin Decline Without Overt Bleeding After Transcatheter Aortic Valve ReplacementMarisa Avvedimento, Pedro Cepas-Guillén, Jorge Nuche, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trialRaffaele Piccolo, Paolo Calabrò, Greta Carrara, et al.
Revista Espanola De Cardiologia (English Ed.)|December 26, 2024
Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impactAriana Gonzálvez-García, Pedro Cepas-Guillén, Julien Ternacle, et al.
Journal of Clinical Medicine|June 27, 2024
Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve ImplantationSofia Sammartino, Giulia Laterra, Thomas Pilgrim, et al.
Circulation. Cardiovascular Interventions|October 30, 2024
Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVRMarisa Avvedimento, Pedro Cepas-Guillén, Julien Ternacle, et al.
Circulation. Cardiovascular Interventions|December 20, 2022
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve ImplantationGiuliano Costa, Thomas Pilgrim, Ignacio J Amat Santos, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 12, 2023
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantationTobias Rheude, Giuliano Costa, Flavio Luciano Ribichini, et al.
Circulation. Cardiovascular Interventions|May 20, 2026
Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve ImplantationCristina Aurigemma, Giuliano Costa, Giulia Laterra, et al.
Pageof 18